ACE inhibitor potentiation of bradykinin-induced venoconstriction

British Journal of Pharmacology

Volumn 121, Issue 7, 1997, Pages 1475-1481

  Hecker, Markus ^c   Blaukat, Andree ^b   Bara, Agnieszka T ^a   Müller Esterl, Werner ^b   Busse, Rudi ^a  

^a GOETHE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Ace inhibitors; Acetylcholine; Angiotensin II; Angiotensin (1 7); B2 receptor; Bradykinin; Jugular vein, rabbit; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; BRADYKININ; BRADYKININ B2 RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; MOEXIPRILAT; RAMIPRILAT;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VENOCONSTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; DRUG SYNERGISM; JUGULAR VEINS; MALE; RABBITS; RAMIPRIL; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; VASOCONSTRICTION;

EID: 0030750133     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701281     Document Type: Article

References (35)

1. ABD ALLA, S., BUSCHKO, J., QUITTERER, U., MAIDHOF, A., HAASEMANN, M., BREIPOHL, G., KNOLLE, J & MÜLLER-ESTERL, W. (1993). Structural features of the human bradykinin B2 receptor probed by agonists, antagonists, and anti-idiotypic antibodies. J. Biol. Chem., 268, 17277 17285.
2. AUCH-SCHWELK, W., BOSSALLER, C., CLAUS, M., GRAF, K., GRÃFE, M. & FLECK, E. (1993). ACE inhibitors are endothelium-dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin. Cardiovasc. Res., 27, 312-317.
3. AUCH-SCHWELK, W., DUSKE, E., CLAUS, M., GRAF, K., GRÄFE, M. & FLECK, E. (1995). Endothelium-mediated vasodilation during ACE inhibition, Eur. Heart J., 16, (Suppl. C), 59-65.
4. BLAUKAT, A., ABD ALLA, S., LOHSE, M.J. & MÜLLER-ESTERL, W. (1996). Ligand-induced phosphorylation/dephosphorylation of the endogenous bradykinin B2 receptor from human fibroblasts. J. Biol. Chem., 271, 32366 32374.
5. BOSSALLER, C., AUCH-SCHWELK, W., GRÄFE, M., GRAF, K., BAUMGARTEN, C. & FLECK, E. (1992). Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation. Agents Actions Suppl., 38, 171-177.
6. BUSSE, R. & FLEMING, I. (1996). Molecular responses of endothelial tissue to kinins. Diabetes, 45, (Suppl. 1 ), S8-13.
7. CAMPBELL, D.J., LAWRENCE, A.C., TOWRIE, A., KLADIS, A. & VALENTIJN, A.J. (1991). Differential regulation of angiotensin peptide levels in plasma and kidney of the rat. Hypertension, 18, 763-773.
8. CARMONA, A.K. & JULIANO, L. (1996). Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retroinverso analogues of short peptides and sequences related to angiotensin I and bradykinin. Biochem. Pharmacol., 51, 1051-1060.
9. DERAD, I., DENDORFER, A., BORN, J., DOMINIAK, P. & FEHM, H.L. (1996). Dosisabhängige Effekte der ACE-Hemmung auf das gesunde, isoliert arbeitende Herz. Nieren- und Hochdruckkrankheiten, 25, 206-209.
10. DESTA, B., NAKASHIMA, M., KIRCHENGAST, M., VANHOUTTE, P.M. & BOULANGER, C.M. (1994). Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries. J. Pharmacol. Exp. Ther., 272, 885-891.
11. HALL, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther., 56, 131-190.
12. HARPER, J.W., HEMMI, K. & POWERS, J.C. (1985). Reaction of serine proteases with substituted isocoumarins: discovery of 3,4-dichloroisocoumarin, a new general mechanism based serine protease inhibitor. Biochemistry, 24, 1831-1841.
13. HECKER, M., BENZING, T. & BUSSE, R. (1992). Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme. Agents Actions Suppl., 38/III, 163-170.
14. HECKER, M., BARA, A.T. & BUSSE, R. (1993). Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: Role of endothelium-derived kinins. J. Vasc. Res., 30, 257-262.
15. HECKER, M., MÜLSCH, A., BASSENGE, E., FÖRSTERMANN, U. & BUSSE. R. (1994a). Subcellular localisation and characterization of nitric oxide synthase(s) in endothelial cells physiologic implications. Biochem. J., 299, 247-252.
16. HECKER, M., PÖRSTI, I., BARA, A.T. & BUSSE, R. (1994b). Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation interaction at the receptor level. Br. J. Pharmacol., 111, 238-244.
17. KITAMURA, S., CARBINI, L.A., CARRETERO, O.A., SIMMONS, W.H. & SCICLI, A.G. (1995). Potentiation by aminopeptidase P of blood pressure response to bradykinin. Br. J. Pharmacol., 114, 6-7.
18. 2 vasopressin receptor by a plasma membrane metalloproteinase. J. Biol. Chem., 270, 6476-6481.
19. LINZ, W., WIEMER, G., GOHLKE, P., UNGER, T. & SCHÖLKENS, B.A. (1995). Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev., 47, 25-49.
20. 2 receptor act as inverse agonists in rat myometrial cells. J. Biol. Chem., 269, 25970-25973.
21. LÜCKHOFF, A., BUSSE, R., WINTER, I. & BASSENGE, E. (1987). Characterization of vascular relaxant factor released from cultured endothelial cells. Hypertension, 9, 295-303.
22. MOMBOULI, J.V., ILLIANO, S., NAGAO, T., SCOTT-BURDEN, T. & VANHOUTTE, P.M. (1992). Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ. Res., 71, 137-144.
23. MOROI, M., AKATSUKA, N., FUKAZAWA, M., HARA, K., ISHIKAWA, M., AIKAWA, J., NAMIKI, A. & YAMAGUCHI, T. (1994). Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries. Am. J. Physiol., 266, H583-H589.
24. MUNOZ, C.M. & LEEB-LUNDBERG, L.M. (1992). Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways. J. Biol. Chem., 267, 303-309.
25. MURATA, T., MATSUMOTO, Y., KASHIDA, T., KAMINUMA, O., NAITO, K., IKEZAWA, K. & TSUZURAHARA, K. (1995). Differences among angiotensin-converting enzyme inhibitors in potentiating effects on bradykinin-induced microvascular leakage in guinea pig airways. Jpn. J. Pharmacol, 69, 111-118.
26. NAKAMURA, M., FUNAKOSHI, T., YOSHIDA, H., ARAKAWA, N., SUZUKI, T. & HIRAMORI, K. (1992). Endothelium-dependent vasodilation is augmented by angiotensin converting enzyme inhibitors in healthy volunteers. J. Cardiovasc. Pharmacol, 20, 949-954.
27. PAULA, R.D., LIMA, C.V., KHOSLA, M.C. & SANTOS, R.A. (1995). Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension, 26, 1154-1159.
28. RODRIGUES, M.S., SCHAFFEL, R. & ASSREUY, J. (1992). Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enaprilat and kininpotentiating peptide. Eur. J. Pharmacol., 216, 357-362.
29. ROSCHER, A.A., KLIER, C., DENGLER, R., FAUSSNER, A. & MÜLLER-ESTERL, W. (1990). Regulation of bradykinin action at the receptor level. J. Cardiovasc. Pharmacol., 15, (Suppl 6), S39-S43.
30. TRIFILIEFF, A., LACH, E., MOUSLI, M., HADDAD, E.B., LANDRY, Y. & GIES, J.P. (1994). Co-solubilization of bradykinin B2 receptors and angiotensin-converting enzyme from guinea pig lung membranes. Biochim. Biophys. Acta, 1191, 109-116.
31. UNGER, T. & GOHLKE, P. (1994). Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovasc. Res., 28, 146-158.
32. VAN WIJNGAARDEN, J., TIO, R.A., VAN GILST, W.H., DE GRAEEF, P.A., DE LANGEN, C.D. & WESSELING, H. (1991). Coronary vasodilation induced by captopril and zofenoprilat: evidence for a prostaglandin-independent mechanism. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 491-495.
33. WELCHES, W.R., BROSNIHAN, K.B. & FERRARIO, C.M. (1993). A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci., 52, 1461-1480.
34. WIEMER, G., SCHÖLKENS, B.A., BECKER, R.H. & BUSSE, R. (1991). Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium- derived bradykinin. Hypertension, 18, 558-563.
35. ZANZINGER, J., ZHENG, X. & BASSENGE, E. (1994). Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc. Res., 28, 209-214.